CME Group Inc.

Valuation Analysis

About the Company

CME Group Inc. en bref

CME Group Inc. (CME) is currently trading at 215,01 € with a market capitalization of 77,7 Md €. The trailing P/E ratio stands at 21.41x, with a forward P/E of 19.07x. The 52-week range spans from 213,42 € to 287,25 €; the current price is 25.1% below the yearly high. Year-over-year revenue growth stands at +14.4%. The net profit margin stands at 63.32%.

💰 Dividende

CME Group Inc. pays an annual dividend of 4,54 € per share, representing a yield of 2.11%. The payout ratio stands at 95.56%. The elevated payout ratio reflects a mature dividend policy.

📊 Avis des analystes

15 analystes évaluent CME Group Inc. (CME) au consensus : Acheter. L'objectif de cours moyen est de 266,98 €, soit un potentiel de +24.17% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 200,72 € à 308,05 €.

CME Group Inc. : la thèse d'investissement en détail

CME Group Inc. (CME) operates in the Financial Services — specifically Financial Data & Stock Exchanges — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 14.4% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 100%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Free cash flow is positive and net margins stand at 63.32%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

Valorisation en contexte

At a PEG of 4.59, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.

À surveiller

• The forward P/E of 19.07x is meaningfully below the trailing 21.41x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 24.17% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy CME Group Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.